Anavex Net Income From Continuing Ops from 2010 to 2024

AVXL Stock  USD 8.38  0.08  0.96%   
Anavex Life Net Loss yearly trend continues to be quite stable with very little volatility. Net Loss may rise above about -40.6 M this year. From the period between 2010 and 2024, Anavex Life, Net Loss regression line of its data series had sample variance of 263.6 T and sample variance of 263.6 T. View All Fundamentals
 
Net Loss  
First Reported
2011-06-30
Previous Quarter
-10.5 M
Current Value
-12.2 M
Quarterly Volatility
4.1 M
 
Yuan Drop
 
Covid
Check Anavex Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Anavex Life's main balance sheet or income statement drivers, such as Interest Expense of 1.3 M, Other Operating Expenses of 67.3 M or Total Operating Expenses of 67.3 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 3.48. Anavex financial statements analysis is a perfect complement when working with Anavex Life Valuation or Volatility modules.
  
Check out the analysis of Anavex Life Correlation against competitors.

Latest Anavex Life's Net Income From Continuing Ops Growth Pattern

Below is the plot of the Net Income From Continuing Ops of Anavex Life Sciences over the last few years. It is Anavex Life's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Anavex Life's overall financial position and show how it may be relating to other accounts over time.
Net Income From Continuing Ops10 Years Trend
Slightly volatile
   Net Income From Continuing Ops   
       Timeline  

Anavex Net Income From Continuing Ops Regression Statistics

Arithmetic Mean(23,392,313)
Coefficient Of Variation(69.40)
Mean Deviation14,078,945
Median(17,453,409)
Standard Deviation16,234,223
Sample Variance263.6T
Range45.3M
R-Value(0.94)
Mean Square Error31T
R-Squared0.89
Slope(3,426,303)
Total Sum of Squares3689.7T

Anavex Net Income From Continuing Ops History

2024-40.6 M
2023-42.8 M
2022-47.5 M
2021-48 M
2020-37.9 M
2019-26.3 M
2018-26.3 M

About Anavex Life Financial Statements

Anavex Life investors utilize fundamental indicators, such as Net Income From Continuing Ops, to predict how Anavex Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Net Loss-42.8 M-40.6 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Anavex Life Sciences is a strong investment it is important to analyze Anavex Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Anavex Life's future performance. For an informed investment choice regarding Anavex Stock, refer to the following important reports:
Check out the analysis of Anavex Life Correlation against competitors.
You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anavex Life. If investors know Anavex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anavex Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.51)
Return On Assets
(0.20)
Return On Equity
(0.30)
The market value of Anavex Life Sciences is measured differently than its book value, which is the value of Anavex that is recorded on the company's balance sheet. Investors also form their own opinion of Anavex Life's value that differs from its market value or its book value, called intrinsic value, which is Anavex Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anavex Life's market value can be influenced by many factors that don't directly affect Anavex Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anavex Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Anavex Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anavex Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.